Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
29A:FRA
Amphastar Pharmaceuticals, Inc
€17.47
+0.84%
(+0.14) 1D
Apr 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 29A...
Open
€17.47
High
€17.47
Low
€17.47
Mkt. cap
953.49M
Avg. vol.
0.00
Volume
0.00
52-wk high
€25.96
52-wk low
€15.26
No. of employees
2K
News stories
From sources across the web
Profile
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products. One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around $20 to $40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally. In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case. In April 2023, Amphastar Pharmaceuticals bought Baqsimi from Eli Lilly in a deal worth over $1bn. Wikipedia
About Amphastar Pharmaceuticals, Inc
CEO-
Employees1.98K
Founded1996
HeadquartersRancho Cucamonga, California, United States
SectorPharmaceutical industry
Websiteamphastar.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
170.53M
174.41M
191.84M
183.10M
Cost of goods sold
85.28M
87.92M
93.19M
97.44M
Cost of revenue
85.28M
87.92M
93.19M
97.44M
Research and development expenses
20.10M
20.08M
22.35M
23.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.86M
24.23M
27.87M
26.75M
Operating expense
47.96M
44.31M
50.23M
50.06M
Total operating expenses
133.24M
132.23M
143.42M
147.50M
Operating income
37.29M
42.18M
48.42M
35.61M
Other non operating income
666.00K
-189.00K
131.00K
215.00K
EBT including unusual items
30.86M
39.34M
21.51M
31.91M
EBT excluding unusual items
30.86M
39.34M
44.61M
31.91M
Income tax expense
5.58M
8.30M
4.16M
7.48M
Effective tax rate
18.07%
21.11%
19.35%
23.45%
Other operating expenses
-
-
-
-
Net income
25.28M
31.03M
17.35M
24.43M
Net profit margin
14.83%
17.79%
9.04%
13.34%
Earnings per share
0.74
0.85
0.93
0.73
Interest and investment income
2.09M
1.92M
2.25M
2.42M
Interest expense
-9.19M
-4.58M
-6.28M
-6.33M
Net interest expenses
-7.10M
-2.66M
-4.04M
-3.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
50.90M
56.80M
62.55M
49.95M
Gain or loss from assets sale
2.00K
30.00K
1.00K
6.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer